How the sprint for a coronavirus vaccine transformed Moderna into a $39 billion powerhouse that’s poised to reshape biotech
This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Moderna went from a hot biotech startup to one of the world's best-known companies, boosted most recently by its coronavirus-vaccine program. It says its shot is 94.5% effective at protecting people against COVID-19. While…
bubmagNovember 23, 2020